Linda W. Martin, MD, MPH, lead investigator, primary author of the study and a Professor of Thoracic Surgery at the University of Virginia. (IMAGE)

Alliance for Clinical Trials in Oncology

Linda W. Martin, MD, MPH, lead investigator, primary author of the study and a Professor of Thoracic Surgery at the University of Virginia.

Caption

“These results are exciting because they give us a new, successful blueprint for treating stage III lung cancer that has traditionally been difficult to manage,” said Linda W. Martin, MD, MPH, lead investigator, primary author of the study and a Professor of Thoracic Surgery at the University of Virginia. “This study shows that combining chemotherapy with immunotherapy can help more patients with lung cancer involving mediastinal nodes undergo complete cancer resection, improving their long‑term health.”

Credit

UVA

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.